Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 44

Adult ID

HIV-STD-TB

Trainee
Symposium

11 - HIV Clinical State of the Art: At the Cutting Edge

Thursday, September 30, 2021
11:00 AM - 12:15 PM EDT

    Moderator(s)

  • Wendy Armstrong, MD

    Professor of Medicine
    Emory University
    Atlanta, GA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Anna Person, MD

    Associate Professor of Medicine
    Vanderbilt University Medical Center
    Nashville, Tennessee, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Speaker(s)

  • Rachel Bender Ignacio, MD MPH

    Assistant Professor
    University of Washington/Fred Hutchinson Cancer Research Center
    Seattle, WA, United States

    Abbvie (Individual(s) Involved: Self): Consultant; SeaGen (Individual(s) Involved: Self): Consultant

  • Melanie Thompson, MD

    Principal Investigator
    AIDS Research Consortium of Atlanta
    Atlanta, GA, United States

    Cepheid, Inc (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Cytodyn, Inc (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Frontier Biotechnologies (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Gilead Sciences (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; GlaxoSmithKline (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Merck Sharp Dohme (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; ViiV Healthcare (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support

  • DD

    Demetre Daskalakis, MD

    Deputy Commissioner
    New York City Department of Health and Mental Hygiene
    New York, New York, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Wendy Armstrong, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Anna K. Person, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rachel A. Bender Ignacio, MD MPH: Abbvie (Individual(s) Involved: Self): Consultant; SeaGen (Individual(s) Involved: Self): Consultant
Melanie A. Thompson, MD: Cepheid, Inc (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Cytodyn, Inc (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Frontier Biotechnologies (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Gilead Sciences (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; GlaxoSmithKline (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Merck Sharp Dohme (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; ViiV Healthcare (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support
Demetre Daskalakis, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • discuss COVID-19 risks and considerations for people with HIV
  • evaluate the use of new drugs for treating HIV
  • assess progress toward ending the HIV epidemic in the U.S.

Presentations:

  • COVID-19 in PWH; epidemiology, prevention, and treatment

    Speaker: Rachel A. Bender Ignacio, MD MPH – University of Washington/Fred Hutchinson Cancer Research Center

  • In the Pipeline: New Drugs for HIV Treatment

    Speaker: Melanie A. Thompson, MD – AIDS Research Consortium of Atlanta

  • Progress on the End the HIV Epidemic Initiative

    Speaker: Demetre Daskalakis, MD – New York City Department of Health and Mental Hygiene